Evidence map›Paper›PMID 35655070›Full record

ArticleScientific reports2022

Complex effects on Ca

Benjamin J Grosso, Audra A Kramer, Sidharth Tyagi, Daniel F Bennett, Cynthia J Tifft, Precilla D'Souza, Michael F Wangler, Ellen F Macnamara, Ulises Meza, Roger A Bannister

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Phenotypic variability in cases with CACNA1A mutation.European journal of pediatrics · 2025
    Article
  5. Pin1 promotes human CaCell communication and signaling : CCS · 2024
    Article
  6. Article
  7. P/Q type (CaMolecular neurobiology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The genotype-phenotype correlations of theFrontiers in molecular neuroscience · 2023
    Article
  13. Developing a pathway to clinical trials forTherapeutic advances in rare disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Benjamin J Grosso *Departments of Pathology/Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene Street, Room 208A, Baltimore, MD, 21201, USA.
Audra A Kramer *Departments of Pathology/Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene Street, Room 208A, Baltimore, MD, 21201, USA.
Sidharth TyagiMedical Scientist Training Program, Department of Neurology, Yale School of Medicine, New Haven, CT, 06520, USA.
Daniel F BennettDepartments of Pathology/Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene Street, Room 208A, Baltimore, MD, 21201, USA.
Cynthia J TifftNational Institutes of Health Undiagnosed Diseases Program, Common Fund, National Institutes of Health, Bethesda, MD, 20892, USA.
Precilla D'SouzaNational Institutes of Health Undiagnosed Diseases Program, Common Fund, National Institutes of Health, Bethesda, MD, 20892, USA.
Michael F WanglerDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Ellen F MacnamaraNational Institutes of Health Undiagnosed Diseases Program, Common Fund, National Institutes of Health, Bethesda, MD, 20892, USA.
Ulises MezaDepartment of Physiology and Biophysics, School of Medicine, Autonomous University of San Luis Potosí, Carranza #2405, SLP 78210, San Luis Potosí, Mexico.
Roger A BannisterDepartments of Pathology/Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene Street, Room 208A, Baltimore, MD, 21201, USA. rbannister@som.umaryland.edu.
University of Maryland, Baltimore · USNational Institutes of Health · USAutonomous University of San Luis Potosí · MXBaylor College of Medicine · USNational Human Genome Research Institute · USYale University · US

Funding

Medical Scientist Training ProgramT32GM136651 · NIGMS · YALE UNIVERSITY · PI BARBARA I KAZMIERCZAK · 2020 to 2026
$16.5M
Interdisciplinary Training Program Muscle BiologyT32AR007592 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI Aikaterini Kontrogianni-Konstantopoulos · 1996 to 2026
$11.7M
Rad and amyotrophic lateral sclerosis (ALS)R01NS103777 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI HERNANDEZ-OCHOA, ERICK OMAR · 2018 to 2022
$1.7M
Advanced components for an existing spinning disk confocal in an established core imaging facilityS10OD026698 · OD · UNIVERSITY OF MARYLAND BALTIMORE · PI BLANPIED, THOMAS A · 2019 to 2019
$274k
NIAMS NIH HHS T32 AR007592NIAMS NIH HHS T32-AR007592NIGMS NIH HHS T32 GM136651NIGMS NIH HHS T32-GM136651NIH HHS S10 OD026698NINDS NIH HHS R01 NS103777NINDS NIH HHS R01-NS103777
6 · The paper itself

Abstract

P/Q-type Ca

Indexed as

ChannelopathiesNeurodevelopmental DisordersAtaxiaCalcium ChannelsCalcium Channels, N-TypeHumansMuscle HypotoniaCACNA1A protein, humanCalcium ChannelsCalcium Channels, N-Type

Identifiers

PMID35655070
PMCPMC9163077
OpenAlexW4281976989

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.